SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018587
Filing Date
2023-11-09
Accepted
2023-11-09 16:17:28
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xlo-20230930x10q.htm   iXBRL 10-Q 1684995
2 EX-10.3 xlo-20230930xex10d3.htm EX-10.3 76409
3 EX-31.1 xlo-20230930xex31d1.htm EX-31.1 13370
4 EX-31.2 xlo-20230930xex31d2.htm EX-31.2 13249
5 EX-32.1 xlo-20230930xex32d1.htm EX-32.1 7859
  Complete submission text file 0001558370-23-018587.txt   5270447

Data Files

Seq Description Document Type Size
6 EX-101.SCH xlo-20230930.xsd EX-101.SCH 29834
7 EX-101.CAL xlo-20230930_cal.xml EX-101.CAL 34389
8 EX-101.DEF xlo-20230930_def.xml EX-101.DEF 133081
9 EX-101.LAB xlo-20230930_lab.xml EX-101.LAB 316481
10 EX-101.PRE xlo-20230930_pre.xml EX-101.PRE 245378
51 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20230930x10q_htm.xml XML 602943
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40925 | Film No.: 231392731
SIC: 2834 Pharmaceutical Preparations